|
1
|
Montalcini T, Romeo S, Ferro Y, Migliaccio
V, Gazzaruso C and Pujia A: Osteoporosis in chronic inflammatory
disease: The role of malnutrition. Endocrine. 43:59–64.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kobayashi M, Sawada K, Yoshimura A,
Yamamoto M, Shimizu A, Shimura K, Komura N, Miyamoto M, Ishida K
and Kimura T: Clinical effects of switching from minodronate to
denosumab treatment in patients with postmenopausal osteoporosis: A
retrospective study. BMC Womens Health. 20(48)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bianco P, Sacchetti B and Riminucci M:
Stem cells in skeletal physiology and endocrine diseases of bone.
Endocr Dev. 21:91–101. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jing H, Liao L, An Y, Su X, Liu S, Shuai
Y, Zhang X and Jin Y: Suppression of EZH2 prevents the shift of
osteoporotic MSC fate to adipocyte and enhances bone formation
during osteoporosis. Mol Ther. 24:217–229. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li CJ, Cheng P, Liang MK, Chen YS, Lu Q,
Wang JY, Xia ZY, Zhou HD, Cao X, Xie H, et al: MicroRNA-188
regulates age-related switch between osteoblast and adipocyte
differentiation. J Clin Invest. 125:1509–1522. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Li Y, Fan L, Hu J, Zhang L, Liao L, Liu S,
Wu D, Yang P, Shen L, Chen J and Jin Y: miR-26a rescues bone
regeneration deficiency of mesenchymal stem cells derived from
osteoporotic mice. Mol Ther. 23:1349–1357. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hu HL, Liu KY, Ram YI, Gao JL and Cao YM:
Long noncoding RNA MIRG induces osteoclastogenesis and bone
resorption in osteoporosis through negative regulation of miR-1897.
Eur Rev Med Pharmacol Sci. 23:10195–10203. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zeng X, Wang Y, Dong Q, Ma MX and Liu XD:
DLX2 activates Wnt1 transcription and mediates Wnt/β-catenin signal
to promote osteogenic differentiation of hBMSCs. Gene.
744(144564)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gao GC, Yang DW and Liu W: LncRNA TERC
alleviates the progression of osteoporosis by absorbing miRNA-217
to upregulate RUNX2. Eur Rev Med Pharmacol Sci. 24:526–534.
2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jiang Y, Wu W, Jiao G, Chen Y and Liu H:
LncRNA SNHG1 modulates p38 MAPK pathway through Nedd4 and thus
inhibits osteogenic differentiation of bone marrow mesenchymal stem
cells. Life Sci. 228:208–214. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen RS, Zhang XB, Zhu XT and Wang CS:
LncRNA Bmncr alleviates the progression of osteoporosis by
inhibiting RANML-induced osteoclast differentiation. Eur Rev Med
Pharmacol Sci. 23:9199–9206. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang Y, Li Y, Song HQ and Sun GW: Long
non-coding RNA LINC00899 as a novel serum biomarker for diagnosis
and prognosis prediction of acute myeloid leukemia. Eur Rev Med
Pharmacol Sci. 22:7364–7370. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang CG, Liao Z, Xiao H, Liu H, Hu YH,
Liao QD and Zhong D: LncRNA KCNQ1OT1 promoted BMP2 expression to
regulate osteogenic differentiation by sponging miRNA-214. Exp Mol
Pathol. 107:77–84. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang N, Hu X, He S, Ding W, Wang F, Zhao
Y and Huang Z: LncRNA MSC-AS1 promotes osteogenic differentiation
and alleviates osteoporosis through sponging microRNA-140-5p to
upregulate BMP2. Biochem Biophys Res Commun. 519:790–796.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ding J, Sha L, Shen P, Huang M, Cai Q and
Li J: MicroRNA-18a inhibits cell growth and induces apoptosis in
osteosarcoma by targeting MED27. Int J Oncol. 53:329–338.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bellavia D, De Luca A, Carina V, Costa V,
Raimondi L, Salamanna F, Alessandro R, Fini M and Giavaresi G:
Deregulated miRNAs in bone health: Epigenetic roles in
osteoporosis. Bone. 122:52–75. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang T, Zhang C, Wu C, Liu J, Yu H, Zhou
X, Zhang J, Wang X, He S, Xu X, et al: miR-765 inhibits the
osteogenic differentiation of human bone marrow mesenchymal stem
cells by targeting BMP6 via regulating the BMP6/Smad1/5/9 signaling
pathway. Stem Cell Res Ther. 11(62)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang Y, Liu Y, Wu M, Wang H, Wu L, Xu B,
Zhou W, Fan X, Shao J and Yang T: MicroRNA-664a-5p promotes
osteogenic differentiation of human bone marrow-derived mesenchymal
stem cells by directly downregulating HMGA2. Biochem Biophys Res
Commun. 521:9–14. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li ZH, Hu H, Zhang XY, Liu GD, Ran B,
Zhang PG, Liao MM and Wu YC: miR-291a-3p regulates the BMSCs
differentiation via targeting DKK1 in dexamethasone-induced
osteoporosis. Kaohsiung J Med Sci. 36:35–42. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li W, Meng Z, Zou T, Wang G, Su Y, Yao S
and Sun X: miR-374a activates Wnt/β-catenin signaling to promote
osteosarcoma cell migration by targeting WIF-1. Pathol Oncol Res.
26:533–539. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Komori T: Requisite roles of Runx2 and
Cbfb in skeletal development. J Bone Miner Metab. 21:193–197.
2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhao Z, Zhao M, Xiao G and Franceschi RT:
Gene transfer of the Runx2 transcription factor enhances osteogenic
activity of bone marrow stromal cells in vitro and in vivo. Mol
Ther. 12:247–253. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li L and Jiang D: Hypoxia-responsive
miRNA-21-5p inhibits Runx2 suppression by targeting SMAD7 in
MC3T3-E1 cells. J Cell Biochem. 120:16867–16875. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cheng F, Yang MM and Yang RH:
miRNA-365a-3p promotes the progression of osteoporosis by
inhibiting osteogenic differentiation via targeting RUNX2. Eur Rev
Med Pharmacol Sci. 23:7766–7774. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yang L, Zeng Z, Kang N, Yang JC, Wei X and
Hai Y: Circ-VANGL1 promotes the progression of osteoporosis by
absorbing miRNA-217 to regulate RUNX2 expression. Eur Rev Med
Pharmacol Sci. 23:949–957. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kosmacheva SM, Volk MV, Yeustratenka TA,
Severin IN and Potapnev MP: In vitro growth of human umbilical
blood mesenchymal stem cells and their differentiation into
chondrocytes and osteoblasts. Bull Exp Biol Med. 145:141–145.
2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tong X, Gu PC, Xu SZ and Lin XJ: Long
non-coding RNA-DANCR in human circulating monocytes: A potential
biomarker associated with postmenopausal osteoporosis. Biosci
Biotechnol Biochem. 79:732–737. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang Q, Li Y and Zhang Y, Ma L, Lin L,
Meng J, Jiang L, Wang L, Zhou P and Zhang Y: LncRNA MEG3 inhibited
osteogenic differentiation of bone marrow mesenchymal stem cells
from postmenopausal osteoporosis by targeting miR-133a-3p. Biomed
Pharmacother. 89:1178–1186. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Han Y, Liu C, Lei M, Sun S, Zheng W, Niu Y
and Xia X: LncRNA TUG1 was upregulated in osteoporosis and
regulates the proliferation and apoptosis of osteoclasts. J Orthop
Surg Res. 14(416)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shen JJ, Zhang CH, Chen ZW, Wang ZX, Yang
DC, Zhang FL and Feng KH: LncRNA HOTAIR inhibited osteogenic
differentiation of BMSCs by regulating Wnt/beta-catenin pathway.
Eur Rev Med Pharmacol Sci. 23:7232–7246. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhou W, Gong J, Chen Y, Chen J, Zhuang Q,
Cao J, Mei Z and Hu B: Long noncoding RNA LINC00899 suppresses
breast cancer progression by inhibiting miR-425. Aging (Albany NY).
11:10144–10153. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dong X, Xu X and Guan Y: LncRNA LINC00899
promotes progression of acute myeloid leukaemia by modulating
miR-744-3p/YY1 signalling. Cell Biochem Funct. 38:955–964.
2020.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Zhang Y, Chen B, Li D, Zhou X and Chen Z:
LncRNA NEAT1/miR-29b-3p/BMP1 axis promotes osteogenic
differentiation in human bone marrow-derived mesenchymal stem
cells. Pathol Res Pract. 215:525–531. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kelch S, Balmayor ER, Seeliger C, Vester
H, Kirschke JS and van Griensven M: miRNAs in bone tissue correlate
to bone mineral density and circulating miRNAs are gender
independent in osteoporotic patients. Sci Rep.
7(15861)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Park S, Lee M, Chun CH and Jin EJ: The
lncRNA, nespas, is associated with osteoarthritis progression and
serves as a potential new prognostic biomarker. Cartilage.
10:148–156. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Delsin LEA, Roberto GM, Fedatto PF, Engel
EE, Scrideli CA, Tone LG and Brassesco MS: Downregulated
adhesion-associated microRNAs as prognostic predictors in childhood
osteosarcoma. Pathol Oncol Res. 25:11–20. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fan Q, Li Y, Sun Q, Jia Y, He C and Sun T:
miR-532-3p inhibits osteogenic differentiation in MC3T3-E1 cells by
downregulating ETS1. Biochem Biophys Res Commun. 525:498–504.
2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Xiaoling G, Shuaibin L and Kailu L:
MicroRNA-19b-3p promotes cell proliferation and osteogenic
differentiation of BMSCs by interacting with lncRNA H19. BMC Med
Genet. 21(11)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Yang GZ, Zhang WJ, Ding X, Zhang XK, Jiang
XQ and Zhang ZY: Effect of overexpression of transcription factor
Runx2 and Osterix on osteogenic differentiation of endothelial
cells. Shanghai Kou Qiang Yi Xue. 26:353–357. 2017.PubMed/NCBI(In Chinese).
|
|
41
|
Fu L, Peng S, Wu W, Ouyang Y, Tan D and Fu
X: LncRNA HOTAIRM1 promotes osteogenesis by controlling JNK/AP-1
signalling-mediated RUNX2 expression. J Cell Mol Med. 23:7517–7524.
2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chen X, Li J, Liang D, Zhang L and Wang Q:
LncRNA AWPPH participates in the development of non-traumatic
osteonecrosis of femoral head by upregulating Runx2. Exp Ther Med.
19:153–159. 2020.PubMed/NCBI View Article : Google Scholar
|
